RHUDEX Trademark
Trademark Overview
On Monday, August 11, 2003, a trademark application was filed for RHUDEX with the United States Patent and Trademark Office. The USPTO has given the RHUDEX trademark a serial number of 78285532. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by Avidex Limited. The RHUDEX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics
Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology
General Information
| Serial Number | 78285532 |
| Word Mark | RHUDEX |
| Filing Date | Monday, August 11, 2003 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, September 28, 2012 |
| Registration Number | 2943640 |
| Registration Date | Tuesday, April 26, 2005 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 1, 2005 |
Trademark Statements
| Goods and Services | Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics |
| Goods and Services | Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases |
| Goods and Services | Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 28, 2012 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 28, 2012 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 28, 2012 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | MEDIGENE LIMITED |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | OXFORDSHIRE OX14 4RX
GB |
| Party Name | Avidex Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 11 - Company |
| Address | Oxfordshire OX14 4RX
GB |
| Party Name | Avidex Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 11 - Company |
| Address | Oxfordshire OX14 4RX
GB |
| Party Name | Avidex Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | Oxfordshire OX14 4RX
GB |
Trademark Events
| Event Date | Event Description |
| Friday, September 28, 2012 | CANCELLED SEC. 8 (6-YR) |
| Wednesday, December 17, 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, December 17, 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 19, 2007 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, April 26, 2005 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 1, 2005 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 12, 2005 | NOTICE OF PUBLICATION |
| Tuesday, November 30, 2004 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, November 29, 2004 | ASSIGNED TO LIE |
| Sunday, November 21, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 30, 2004 | AMENDMENT FROM APPLICANT ENTERED |
| Thursday, August 5, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 5, 2004 | Sec. 1(B) CLAIM DELETED |
| Thursday, August 5, 2004 | PAPER RECEIVED |
| Tuesday, February 3, 2004 | NON-FINAL ACTION MAILED |
| Saturday, January 24, 2004 | ASSIGNED TO EXAMINER |
